ALPS Group Inc ALPS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.39
- Day Range
- $0.38–0.40
- 52-Week Range
- $0.23–15.00
- Bid/Ask
- $0.38 / $0.39
- Shares Outstanding
- 166.40M
- Market Cap
- $65.73M
- Volume/Avg
- 14,806 / 72,114
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 89
- Website
- https://www.alps-holdings.com
Valuation
|
Metric
|
ALPS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 13.36 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ALPS
|
|---|---|
Quick Ratio | 0.20 |
Current Ratio | 0.36 |
Interest Coverage | −40.32 |
Quick Ratio
ALPS
Profitability
|
Metric
|
ALPS
|
|---|---|
Return on Assets (Normalized) | −53.78% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ALPS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|nD<M&@? | LOCK|P@QD | $128B | |||
| Moderna Inc
MRNA
| LOCK|&f&K^N | LOCK|g> | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|?>!?mL | LOCK|<F?< | $76B | |||
| argenx SE ADR
ARGX
| LOCK|^jp^$KM | LOCK|fLQ | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|p>#^#z | LOCK|Jl | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|CTDdS<> | LOCK|N>$>$ | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|$N$^>Z?% | LOCK|r$tND | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|KN<?RWP | LOCK|g>z | $24B | |||
| Incyte Corp
INCY
| LOCK|Sv!?S! | LOCK|>xz | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|bYjG^bh | LOCK|^m | $15B |
United States